Skip to content

Project A3sc - An Atlas of Airways at a Single Cell Level

Project A3sc - An Atlas of Airways at a Single Cell Level

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03437122
Acronym
AAAsc
Enrollment
15
Registered
2018-02-19
Start date
2018-06-20
Completion date
2019-07-16
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory System

Keywords

lung, nasal mucosa, respiratory mucosa

Brief summary

The increasing incidence of chronic respiratory diseases is a public health problem affecting hundreds of thousands of people around the world, including children. Directly exposed to atmospheric aerocontaminants (pollution, allergens), the respiratory tracts represent a complex ecosystem that involves different cells that develop complex interactions with the surrounding connective tissue but also with their rich immune environment and with the microbiota. Although a pathophysiological continuum is postulated between the nasal and bronchial airways in certain diseases, such as allergic diseases, we have identified broad gradients in gene expression between nasal and bronchial samples. This is why cellular variability throughout the respiratory tree needs to be studied in detail. The sequencing of RNAs specifically present in a particular cell, and its comparison with neighboring cells, allows us to document precise cellular contributions and intercellular relationships. Our project will establish protocols to stabilize airway swabs by brushing and/or biopsy, under conditions that will then allow the analysis of gene expression profiles at the single cell level (single cell RNA sequencing). The development of the "single cell" stabilisation and analysis protocol will first be carried out on primary respiratory epithelium cultures and then extended to respiratory specimens taken from healthy volunteers. Through sampling at several levels of the respiratory tree, variations in expression along the tracheobronchial axis will be fully documented. Finally, the interaction between the epithelial compartment and the immunological compartment will be studied by analyzing gene expression on a single cell in different physiopathological contexts.

Interventions

PROCEDUREBronchoscopy

Multiple level sampling of the respiratory mucosa (cytology brush and biopsies forceps)

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* age ≥ 18 years and \<40 years * non-smoker * absence of known acute or chronic disease * absence of symptoms suggestive of progressive disease * normal clinical examination

Exclusion criteria

* recent rhino-bronchial infection (\<6 weeks) * mental disability * pregnant women (a urine test will be performed for all women of childbearing age)

Design outcomes

Primary

MeasureTime frame
Number of samples usable6 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORSylvie LEROY, Dr

Centre Hospitalier Universitaire de Nice

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026